Skip to main content

Want a detailed portfolio tracker?

MindWalk (HYFT) P/E (2017 - 2026)

MindWalk (HYFT) P/E from Jan 3, 2017 to Jun 3, 2026. The TTM MindWalk (HYFT) P/E is -8.52. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MindWalk (HYFT)

YearP/EChange
2026-8.52+181.51%
2025-3.03+440.60%
2024-0.56-82.24%
2023-3.15-49.05%
2022-6.19-25.44%
2021-8.30-92.48%
2020-110.37+2251.17%
2019-4.69-16.45%
2018-5.62+205.10%
2017-1.84N/A

Comparison MindWalk (HYFT) P/E with competitors

MindWalk (HYFT) P/E is -8.52.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.20%
ENLVEnlivex Therapeutics Ltd0.15-101.76%
FGENFibroGen Inc0.24-102.82%
TRAWTraws Pharma Inc0.47-105.55%
FBIOFortress Biotech Inc0.71-108.29%
CHRSCoherus Biosciences Inc0.98-111.48%
ORMPOramed Pharmaceuticals Inc1.47-117.30%
AGENAgenus Inc2.05-124.05%
VIVSVivoSim Labs Inc2.54-129.77%
INVAInnoviva Inc3.19-137.44%
CRMDCorMedix Inc3.65-142.80%
ABEOAbeona Therapeutics Inc4.20-149.37%
VXRTVaxart Inc4.26-150.04%
CVACCureVac N.V.4.45-152.20%
SRPTSarepta Therapeutics Inc4.62-154.29%
GLPGGalapagos NV4.86-157.05%
RIGLRigel Pharmaceuticals4.92-157.76%
ZVRAZevra Therapeutics Inc4.97-158.40%
ABUSArbutus Biopharma Corp5.69-166.85%
CGENCompugen Ltd7.38-186.70%
AUPHAurinia Pharmaceuticals Inc9.25-208.62%
ACADAcadia Pharmaceuticals Inc9.59-212.58%
OMEROmeros Corporation9.88-216.05%
PLXProtalix BioTherapeutics Inc9.91-216.35%
SPROSpero Therapeutics Inc10.73-226.04%
ADMAAdma Biologics Inc11.33-233.04%
SVASinovac Biotech Ltd11.44-234.28%
TBPHTheravance Biopharma Inc11.78-238.27%
HRMYHarmony Biosciences Holdings Inc12.18-243.02%
TGTXTG Therapeutics Inc13.18-254.75%
INCYIncyte Corp13.38-257.12%
SABSSAB Biotherapeutics Inc14.06-265.06%
XOMAXOMA Corp14.95-275.48%
REGNRegeneron Pharmaceuticals Inc14.98-275.89%
PBYIPuma Biotechnology Inc15.05-276.71%
EXELExelixis Inc15.79-285.45%
NAGENiagen Bioscience Inc16.35-292.03%
CPRXCatalyst Pharmaceuticals Inc17.34-303.65%
MDXGMimedx Group Inc17.38-304.01%
ARGXArgen X SE23.07-370.89%
HALOHalozyme Therapeutics Inc23.20-372.41%
XOMAOXOMA Corp25.34-397.58%
VRTXVertex Pharmaceuticals Inc25.66-401.24%
XOMAPXOMA Corp25.67-401.40%
CTMXCytomX Therapeutics Inc25.70-401.73%
ASNDAscendis Pharma A/S26.35-409.44%
RPRXRoyalty Pharma plc - Class A27.50-422.84%
SLNOSoleno Therapeutics Inc29.02-440.68%
LGNDLigand Pharmaceuticals Inc - Class B30.19-454.43%
BMRNBiomarin Pharmaceutical Inc37.51-540.39%
APLSApellis Pharmaceuticals Inc39.02-558.17%
KRYSKrystal Biotech Inc39.70-566.11%
GMABGenmab40.20-572.05%
ONCBeiGene Ltd67.03-886.99%
TECHBio-Techne Corp68.59-905.41%
VCELVericel Corp80.63-1046.71%
PHARPharming Group N.V.87.74-1130.20%
ALNYAlnylam Pharmaceuticals Inc124.93-1566.91%
TLXTelix Pharmaceuticals Ltd139.89-1742.52%
CORTCorcept Therapeutics Inc158.39-1959.72%